$GENB 3 SEC Filings

Filed On	Filing
12 Mar 2026	Form 3: Pioneering Medicines 02, Llc, 10% owner Holds 1,562,500 shares of Common Stock
26 Feb 2026	Form 3: Afeyan Noubar, Director and 7 others Holds 25,016,458 shares of Common Stock
26 Feb 2026	Form 3: Afeyan Noubar, Director and 6 others Holds 25,016,458 shares of Common Stock
26 Feb 2026	Form 3: Nally Michael, Director Holds 552,707 shares of Common Stock
26 Feb 2026	Form 3: Martin Sean, Chief Legal Officer & GC
26 Feb 2026	Form 3: Silvers Jason, President & CFO
26 Feb 2026	Form 3: Parker Paul Gray, Director
26 Feb 2026	Form 3: Simonian Nancy A, Director
26 Feb 2026	Form 3: Mendillo Jane L, Director
26 Feb 2026	Form 3: Lee Laurie Anne, Chief Medical Officer
26 Feb 2026	Form 3: Grigoryan Gevorg, Chief Technology Officer Holds 659,973 shares of Common Stock
26 Feb 2026	Form 3: Grous Beth, Chief People Officer
26 Feb 2026	Form 3: Bancel Stephane, Director Holds 460,829 shares of Common Stock
26 Feb 2026	Form 3: Vessey Rupert, Director
26 Feb 2026	Form 3: Khakoo Aarif, Chief Scientific Officer
26 Feb 2026	Form 3: Arnold Frances, Director Holds 232,472 shares of Common Stock
26 Feb 2026	Form 3: Fanucci Marsha, Director

Comments